978Indexed trials
canonical disease area
Parkinson's Disease
Intelligence
Parkinson's Disease intelligence: 978 indexed trials, 225 recruiting studies, 527 sponsors across 67 countries.
225Recruiting
527Sponsors
67Countries
Leading sponsors
Merck Sharp & Dohme LLC4716 recruiting
Washington University School of Medicine103 recruiting
Radboud University Medical Center102 recruiting
Bial - Portela C S.A.100 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)91 recruiting
AbbVie91 recruiting
University of Michigan83 recruiting
InSightec84 recruiting
Boehringer Ingelheim80 recruiting
UCB Pharma70 recruiting
University Hospital, Grenoble71 recruiting
University of Florida72 recruiting
Geographic activity
United States395trials
France112trials
Italy100trials
Germany87trials
Canada86trials
Spain85trials
United Kingdom76trials
China66trials
Turkey (Türkiye)52trials
Taiwan48trials
Israel47trials
Brazil47trials
Leading interventions
Pembrolizumab32trials
Cisplatin13trials
Carboplatin11trials
Rotigotine8trials
Deep Brain Stimulation7trials
pembrolizumab6trials
Exercise6trials
Paclitaxel6trials
tDCS5trials
Docetaxel5trials
Pemetrexed4trials
Pimavanserin4trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.